APP-11肽对糖尿病大鼠肾脏的保护作用

首都医科大学学报 ›› 2002, Vol. 23 ›› Issue (1): 37-40.

APP-11肽对糖尿病大鼠肾脏的保护作用

贾克宝¹, 赵志伟¹, 张人玲¹, 艾厚喜¹, 赵咏梅¹, 姬志娟¹, 孙异临², 盛树力¹

1. 首都医科大学宣武医院脑老化研究实验室;2. 北京市神经外科研究所

收稿日期:2001-12-05 修回日期:1900-01-01 出版日期:2002-01-15 发布日期:2002-01-15

Protective Effect of APP-11 Mel Peptide on Kidney in Diabetic Rats

Jia Kebao¹, Zhao Zhiwei¹, Zhang Renling¹, Ai Houxi¹, Zhao Yongmei¹, Ji Zhijuan¹, Sun Yilin², Sheng Shuli¹

1. Beijing Research Laboratory for Brain Aging, Xuanwu Hospital, Capital University of Medical Sciences;2. Beijing Neurosurgical Instistute

Received:2001-12-05 Revised:1900-01-01 Online:2002-01-15 Published:2002-01-15

摘要/Abstract

摘要： 为研究APP-11肽对糖尿病(DM)大鼠肾脏病变的保护作用,用链脲菌素诱发大鼠糖尿病,皮下注射APP-11肽4周,进行血尿素氮、肌酐、24h尿白蛋白测定,并取肾脏皮质切片进行电镜观察。结果,DM大鼠血糖升高,胰岛素降低,血尿素氮增加,尿白蛋白排出量明显增加。电镜显示肾小球基底膜增厚,内皮细胞孔增大,足突断裂融合。应用APP-11肽组虽然未见血糖及其调节激素的改变,但尿素氮和尿白蛋白排出量明显减少;肾皮质超微结构趋于正常。结果提示APP-11肽对DM肾病具有明显改善作用,但有关机制还有待进一步研究。

关键词: APP-11肽, 糖尿病大鼠, 肾病

Abstract: To observe the protective effect of D-Amyloid precursor protein 63～73 named APP-11 mer peptide from diabetic nephropathy, the peptide was administrated by subcutaneous injection for 4 weeks to diabetic rats induced by streptozotocine. The concentration of glucose and its regulated hormones, urea nitrogen and creatinine in the blood were determined at the end of experiment for 3 groups, hade normal group, diabetic group and diabetic group treated by APP-11 mer peptide. The difference of excretion of uric albumin in the above mentioned 3 groups was also detected, and the kidney cortex was taken for ultrastructure research. The results showed that diabetic rats had much more excretion of uric albumin than that of normal rats and diabetic rats treated by APP-11 mer peptide. Although no effect was observed on the concentration of blood sugar, insulin, glucagon and creatinine, urea nitrogen was decreased in the rats treated by APP-11 mer peptide. On the ultrastructure, thickness of basic membrane and enlargement of the endothelial hole of glomerulus in diabetic kidney were found, but APP-11 mel peptide could improve their changes significantly. The results showed that APP-11 mer peptide can improve the diabetic nephropathy, although no one knows the mechanism.

Key words: APP-11 peptide, diabetic rats, nephropathy

中图分类号:

R587.2

贾克宝;赵志伟;张人玲;艾厚喜;赵咏梅;姬志娟;孙异临;盛树力. APP-11肽对糖尿病大鼠肾脏的保护作用[J]. 首都医科大学学报, 2002, 23(1): 37-40.

Jia Kebao;Zhao Zhiwei;Zhang Renling;Ai Houxi;Zhao Yongmei;Ji Zhijuan;Sun Yilin;Sheng Shuli. Protective Effect of APP-11 Mel Peptide on Kidney in Diabetic Rats[J]. Journal of Capital Medical University, 2002, 23(1): 37-40.

[1]	黄琪, 周亦伦, 孙雪峰. 共享外周循环对糖尿病肾病小鼠肾损伤的影响[J]. 首都医科大学学报, 2022, 43(5): 674-679.
[2]	徐潇漪, 王国勤, 程虹, 赵智睿, 董鸿瑞, 孙丽君. 小剂量利妥昔单抗治疗特发性膜性肾病的疗效及其影响因素[J]. 首都医科大学学报, 2022, 43(5): 680-686.
[3]	于天宇, 姜世敏, 高红梅, 邹古明, 李文歌. 糖尿病肾病慢性肾脏病4期患者肾脏临床及病理因素与预后的关系[J]. 首都医科大学学报, 2022, 43(5): 707-712.
[4]	郭康林, 程一春, 葛树旺, 徐钢. IgA肾病国际风险预测工具在中国人群中的预测效果评价[J]. 首都医科大学学报, 2022, 43(5): 713-719.
[5]	刘怡均, 林向英, 张燕. 中文版世界卫生组织生存质量测定量表简表用于终末期肾病的信效度验证[J]. 首都医科大学学报, 2021, 42(4): 635-641.
[6]	张冬雪, 林梅, 周璿, 刘文燕, 谷雅楠, 王左敏. 牙周状况对糖尿病肾病患者血糖控制的影响[J]. 首都医科大学学报, 2021, 42(2): 306-311.
[7]	卢晶, 杨卫利, 杨芳远, 曹曦, 杨金奎. 医学研究的凿光探秘者——杨金奎教授[J]. 首都医科大学学报, 2020, 41(5): 849-853.
[8]	李彬, 崔丽梅, 吕纳强, 严晔华, 郑晓敏, 陶静, 刘翠平. 初诊2型糖尿病患者糖尿病肾病与幽门螺旋杆菌感染的关系[J]. 首都医科大学学报, 2020, 41(1): 27-30.
[9]	王蕤, 吴素萍, 徐品颖. 血浆miRNA-320C和miRNA-6088对Ⅱ型糖尿病肾病的诊断价值[J]. 首都医科大学学报, 2019, 40(3): 466-472.
[10]	赵明月, 刘博, 王鹏, 杨毅. 2型糖尿病患者肾脏病变与听力损失的相关性[J]. 首都医科大学学报, 2019, 40(1): 27-34.
[11]	宋丽妮, 刘敬怡, 张怡尘, 曹曦, 袁明霞, 杨金奎. 糖尿病肾病早期诊断标志物的研究新进展[J]. 首都医科大学学报, 2017, 38(2): 145-150.
[12]	刘迎新, 邹大威, 耿建国, 高彦彬, 尚雅文, 李娇阳, 龚慕辛, 彭麒朕. 糖肾宁对自发性2型糖尿病KK-Ay小鼠肾组织HGF表达的影响[J]. 首都医科大学学报, 2015, 36(5): 747-750.
[13]	杨晓勇, 任亮, 王玮, 刘航, 胡小鹏, 张小东. 肾移植受者BK病毒感染的单中心回顾性研究[J]. 首都医科大学学报, 2015, 36(3): 459-464.
[14]	黄雯, 陈燊, 李晓璐, 张红, 杨敏, 张梅. 内源性硫化氢在糖尿病大鼠肾脏的变化及作用[J]. 首都医科大学学报, 2015, 36(3): 505-507.
[15]	王馨瑶, 耿建国, 高彦彬, 李娇阳, 周盛楠, 邹大威, 刘迎新. 芪卫颗粒对糖尿病肾病大鼠足细胞CD2AP表达的影响[J]. 首都医科大学学报, 2015, 36(2): 239-243.